Physician profile
Benjamin C Dudley
NPI 1669682811
$4,813.90
in general payments reported to CMS, 2019-2025
43 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $265 · 2021: $564 · 2022: $926 · 2023: $771 · 2024: $1,140 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $710.41 | 2019-2024 | Rezum Generator |
| Astellas Pharma US INC | $563.72 | 2020-2023 | Myrbetriq, Xtandi, Veozah |
| Glaxosmithkline, LLC. | $328.36 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Olympus Corporation of The Americas | $279.58 | 2019 | |
| Astellas Pharma Global Development | $261.44 | 2024-2025 | Xtandi |
| Olympus America INC. | $216.74 | 2021-2025 | Gyrus Acmi, Itind System |
| Pfizer INC. | $164.09 | 2023-2024 | |
| Urogen Pharma, INC. | $150.57 | 2020-2025 | Jelmyto |
| Telix Pharmaceuticals | $149.51 | 2024 | Illuccix |
| Myriad Genetic Laboratories, INC. | $138.02 | 2022-2023 | Myrisk, Prolaris |
| Laborie Medical Technologies Corp. | $134.35 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $130.12 | 2021-2023 | Urolift |
| 180 Medical, INC. | $128.67 | 2021-2023 | Cure Ultra Catheter |
| Actelion Pharmaceuticals US, INC. | $125.10 | 2022 | |
| Ferring Pharmaceuticals INC. | $124.96 | 2024 | Adstiladrin |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $121.29 | 2022-2025 | Lupron Depot |
| Janssen Pharmaceuticals, INC | $98.03 | 2020-2023 | Xarelto |
| Janssen Biotech, INC. | $89.77 | 2021-2023 | Erleada |
| Ambu INC. | $79.14 | 2024 | |
| Csl Behring | $78.87 | 2021-2023 | Kcentra |
| Dornier Medtech America, INC | $69.35 | 2022 | |
| Agiliti Surgical, INC. | $66.01 | 2020 | |
| Procept Biorobotics Corporation | $60.86 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Polynovo North America LLC | $52.84 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $50.97 | 2022-2025 | Bard X-Force Balloon Dilation Catheter, Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $43.53 | 2023 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $34.81 | 2024 | Provenge |
| Vertex Pharmaceuticals Incorporated | $33.61 | 2024 | |
| Immunitybio, INC. | $33.28 | 2024 | |
| Endo Pharmaceuticals INC. | $31.51 | 2021-2023 | Aveed, Xiaflex |
| Dentsply Ih Ab | $31.31 | 2021 | |
| Blue Earth Diagnostics | $29.80 | 2021-2022 | |
| Hollister Incorporated | $29.18 | 2021 | |
| Neotract INC. | $25.38 | 2020 | |
| United Therapeutics Corporation | $24.18 | 2022 | |
| Urovant Sciences INC | $22.01 | 2022 | |
| Braintree Laboratories, INC. | $21.58 | 2022 | |
| Srs Medical Systems, INC. | $15.70 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Amgen INC. | $14.36 | 2022 | |
| Hologic Sales and Service, LLC | $14.34 | 2023 | Coolseal Generator |
| Medtronic, INC. | $12.41 | 2021 | |
| Dentsply Ih INC. | $12.12 | 2020 | |
| Photocure INC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Dudley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.